Date: Monday, September 14, 2020
Time: 3:30 pm IST (GMT+05:30)
Registration: Now open at this link
Global enterprises’ immediate response to COVID-19 was ensuring employee safety and securing supply chains. In the months since, a new set of digital solutions has emerged to ensure business continuity and daily operations in the new normal. The acceleration of digital transformation has been particularly profound in the Life Sciences and Medical Devices sectors, with products and service portfolios expanding at a rapid, digitized clip.
Hear from transformation experts about these emerging opportunities, particularly as they relate to telehealth, employee engagement, and patient engagement. During this 45-minute discussion, our panelists will address three key questions:
- How did Life Sciences companies in the Nordic region initially respond to COVID-19?
- How will COVID-19 change priorities and investment in digital initiatives?
- What questions should companies ask while considering new product and services as they emerge from the COVID-19 pandemic?
Hans Poulsen – Lead Consultant, Health Business Unit – Digital, Wipro Limited
Christian Juul-Nielsen – Commercial Lead, Healthcare, DesignIt
Jakob Voldum – Director, Insights & Strategy, DesignIt